首页> 外文期刊>Indian heart journal >The fourth-generation Calcium channel blocker: Cilnidipine
【24h】

The fourth-generation Calcium channel blocker: Cilnidipine

机译:第四代钙通道阻滞剂:西尼地平

获取原文
获取原文并翻译 | 示例
       

摘要

Several classes of antihypertensive agents have been in clinical use, including diuretics, a-blockers, beta-blockers, angiotensin converting enzyme (ACE) inhibitors, angiotensin II type 1 receptor blockers (ARB), and organic calcium channel blockers (CCBs). All these drugs are being currently used in the treatment of Hypertension & various disease conditions of the heart either alone or in combination. Cilnidipine is a new antihypertensive drug distinguished from other L-type Ca2+ channel blockers or even other antihypertensives, which will be useful for selection of antihypertensive drugs according to the pathophysiological condition of a patient.
机译:临床上已经使用了几类抗高血压药,包括利尿药,α受体阻滞剂,β受体阻滞剂,血管紧张素转化酶(ACE)抑制剂,血管紧张素II 1型受体阻断剂(ARB)和有机钙通道阻断剂(CCB)。所有这些药物目前都被单独或联合用于治疗高血压和各种心脏疾病。西尼地平是一种与其他L型Ca2 +通道阻滞剂或什至其他降压药不同的新型降压药,根据患者的病理生理状况,其可用于选择降压药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号